Basit öğe kaydını göster

dc.contributor.authorDerin, Okan
dc.contributor.authorŞeker, Fatma
dc.contributor.authorAksoy, Nilay
dc.contributor.authorYiğit, Pakize
dc.contributor.authorYılmaz, Mesut
dc.contributor.authorMert, Ali
dc.date.accessioned2022-10-20T08:15:42Z
dc.date.available2022-10-20T08:15:42Z
dc.date.issued2022en_US
dc.identifier.citationDerin, O., Şeker, F., Aksoy, N., Yiğit, P., Yılmaz, M. ve Mert, A. (2022). The effect of antimicrobial policy implementation on carbapenem resistance: A university hospital experience. Clinical and Experimental Health Sciences, 12(3), 678-682. https://doi.org/10.33808/clinexphealthsci.1010571en_US
dc.identifier.issn2459-1459
dc.identifier.urihttps://doi.org/10.33808/clinexphealthsci.1010571
dc.identifier.urihttps://hdl.handle.net/20.500.12511/9855
dc.description.abstractObjective: The resistance of Gram-negative bacteria to antibiotics is a global issue that leads to increased mortality and treatment costs. The aim of this study is to see how a newly formed carbapenem control team affected the prevalence of carbapenem-resistant Gram-negative rods and antibiotic consumption expenses in 2017 compared to the year before.Methods: The rate of carbapenem antibiotic usage in Intensive Care Units and Bone Marrow Transplantation services, as well as the findings of culture materials obtained from various body parts of the same patients, between January 1, 2016, and December 31, 2017 were assessed.Results: While there was an ordinary restriction on carbapenem consumption in 2016, carbapenem consumption has been more restricted in 2017. The carbapenem-resistant Gram-negative bacteria patterns of culture materials are examined and compared with Defined Daily Dose data of carbapenems. After the restriction, a significant decrease in the consumption of carbapenems was detected. The decline in carbapenem-resistant Gram-negative bacteria and decreasing antibiotic consumption were found to have a moderately positive correlation (r=0.641, p=0.02). A 60.9% decrease was observed in carbapenem costs after carbapenem restriction, on the other hand, an increase in other unrestricted antibiotics was apparent.Conclusion: Antimicrobial restriction policies can help minimize the rate of carbapenem-resistant Gram-negative rods, which is a serious problem in healthcare. We demonstrated that a decrease in carbapenem-resistant Gram-negative rods isolation rates can lead to a decrease in healthcare-associated infections. Although there is no decrease in the direct antibiotics cost, a drop in carbapenem-resistant may lower the expenses of drastic consequences of infections with carbapenem-resistant and its cost. we can conclude that the Antibiotic Control Policy should be modified based on this new information.en_US
dc.language.isoengen_US
dc.publisherMarmara Universityen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectCarbapenemen_US
dc.subjectResistanceen_US
dc.subjectGram-Negative Bacteriaen_US
dc.titleThe effect of antimicrobial policy implementation on carbapenem resistance: A university hospital experienceen_US
dc.typearticleen_US
dc.relation.ispartofClinical and Experimental Health Sciencesen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalıen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Biyoistatistik ve Tıp Bilişimi Ana Bilim Dalıen_US
dc.authorid0000-0001-6311-5428en_US
dc.authorid0000-0001-8839-5227en_US
dc.authorid0000-0002-5919-1986en_US
dc.authorid0000-0001-8022-7325en_US
dc.authorid0000-0001-8945-2385en_US
dc.identifier.volume12en_US
dc.identifier.issue3en_US
dc.identifier.startpage678en_US
dc.identifier.endpage682en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.33808/clinexphealthsci.1010571en_US
dc.institutionauthorDerin, Okan
dc.institutionauthorŞeker, Fatma
dc.institutionauthorYiğit, Pakize
dc.institutionauthorYılmaz, Mesut
dc.institutionauthorMert, Ali
dc.identifier.wos000863981200020en_US
dc.identifier.pmid1127946en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess